These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6972489)

  • 1. The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.
    Yamada K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):155-60. PubMed ID: 6972489
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new animal model for schizophrenia: cholinergic and serotonergic modulation.
    Borison RL; Havdala HS; Diamond BI
    Commun Psychopharmacol; 1978; 2(3):209-14. PubMed ID: 308873
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
    Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
    Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine increases pilocarpine-induced yawning behavior in paradoxical sleep deprived rats.
    Lobo LL; de Medeiros R; Hipólide DC; Tufik S
    Pharmacol Biochem Behav; 1995 Nov; 52(3):485-8. PubMed ID: 8545463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of responsiveness to dopaminergic agonists.
    Reinstein DK; McClearn D; Isaacson RL
    Brain Res; 1978 Jul; 150(1):216-23. PubMed ID: 566610
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serotonergic and cholinergic systems in the aggression-stereotypy complex produced by amphetamine in mice.
    Roliński Z
    Pol J Pharmacol Pharm; 1977; 29(6):591-602. PubMed ID: 304574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative study of cholinergic-dopaminergic interactions in the central nervous system.
    De Souza H; Palermo-Neto J
    Pharmacology; 1982; 24(4):222-9. PubMed ID: 7201143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between yawning behavior and central serotonergic neuronal system in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):667-72. PubMed ID: 2957600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.
    Ushijima I; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1984; 82(4):301-5. PubMed ID: 6427818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.